PROSCIENTO Trademark

Trademark Overview


On Wednesday, November 30, 2016, a trademark application was filed for PROSCIENTO with the United States Patent and Trademark Office. The USPTO has given the PROSCIENTO trademark a serial number of 87252639. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, February 8, 2024. This trademark is owned by Profil Institute for Clinical Research, Inc.. The PROSCIENTO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials; medical and scientific research services in the fields of diabetes and obesity treatment; medical research; scientific research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development; pharmaceutical drug and medical device development services; pharmaceutical product evaluation; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics and pharmacogenetics; medical and scientific writing for others in the nature of technical writing; providing scientific consulting services regarding clinical research and trials; compiling scientific information regarding clinical research and trials
prosciento

General Information


Serial Number87252639
Word MarkPROSCIENTO
Filing DateWednesday, November 30, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, February 8, 2024
Registration Number5303360
Registration DateTuesday, October 3, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 9, 2017

Trademark Statements


Translation of Words in MarkThe wording "PROSCIENTO" has no meaning in a foreign language.
Goods and ServicesMedical and scientific research, namely, conducting clinical trials; medical and scientific research services in the fields of diabetes and obesity treatment; medical research; scientific research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development; pharmaceutical drug and medical device development services; pharmaceutical product evaluation; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics and pharmacogenetics; medical and scientific writing for others in the nature of technical writing; providing scientific consulting services regarding clinical research and trials; compiling scientific information regarding clinical research and trials

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 6, 2016
Primary Code042
First Use Anywhere DateFriday, December 23, 2016
First Use In Commerce DateFriday, December 23, 2016

Trademark Owner History


Party NamePROSCIENTO, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressChula Vista, CA 91911

Party NamePROSCIENTO, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCHULA VISTA, CA 91911

Party NamePROSCIENTO, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressCHULA VISTA, CA 91911

Party NameProfil Institute for Clinical Research, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChula Vista, CA 91911

Trademark Events


Event DateEvent Description
Saturday, March 4, 2017ASSIGNED TO EXAMINER
Saturday, December 3, 2016NEW APPLICATION ENTERED
Tuesday, December 6, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 1, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, March 7, 2017EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 7, 2017EXAMINERS AMENDMENT E-MAILED
Tuesday, March 7, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 7, 2017PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, March 7, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 7, 2017EXAMINER'S AMENDMENT ENTERED
Wednesday, March 8, 2017EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 8, 2017EXAMINERS AMENDMENT E-MAILED
Wednesday, March 8, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 8, 2017EXAMINER'S AMENDMENT ENTERED
Wednesday, March 8, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 30, 2017ASSIGNED TO LIE
Friday, March 31, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 19, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 9, 2017PUBLISHED FOR OPPOSITION
Tuesday, May 9, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 4, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 11, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, July 11, 2017USE AMENDMENT FILED
Saturday, August 5, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 8, 2017STATEMENT OF USE PROCESSING COMPLETE
Tuesday, August 29, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, August 30, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 3, 2017REGISTERED-PRINCIPAL REGISTER
Monday, October 3, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, August 18, 2023TEAS SECTION 8 & 15 RECEIVED
Thursday, February 8, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, February 8, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, February 8, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, September 6, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 6, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 6, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 6, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 6, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED